BIOSCIENCE HEALTH INNOVATIONS INC. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
BIOSCIENCE HEALTH INNOVATIONS INC. (BHIC) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $50.45 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-08-07
- BIOSCIENCE HEALTH INNOVATIONS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2026-03-31 was $483.08K, a 32.05% increase year-over-year.
- BIOSCIENCE HEALTH INNOVATIONS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2025-03-31 was $365.82K, a 396.39% increase year-over-year.
- BIOSCIENCE HEALTH INNOVATIONS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2024-03-31 was $73.70K.
- BIOSCIENCE HEALTH INNOVATIONS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2023-03-31 was -$2.10K, a 320.19% decline year-over-year.
- BIOSCIENCE HEALTH INNOVATIONS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2025 was -$592.00, a 100.09% decline from fiscal 2024.
- BIOSCIENCE HEALTH INNOVATIONS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2024 was $643.28K, a 8288.04% increase from fiscal 2023.
- BIOSCIENCE HEALTH INNOVATIONS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2023 was $7.67K, a 33.13% decline from fiscal 2022.
- BIOSCIENCE HEALTH INNOVATIONS INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2022 was $11.47K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2026-06-30 | $50.45K 10-Q · filed 2026-08-07 | |||
| 2026-03-31 | $483.08K 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | -$592.00 10-K · filed 2026-03-30 | |||
| 2025-09-30 | $476.91K 10-Q · filed 2025-10-27 | |||
| 2025-06-30 | $636.89K 10-Q · filed 2026-08-07 | |||
| 2025-03-31 | $365.82K 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | $643.28K 10-K · filed 2026-03-30 | |||
| 2024-09-30 | $313.98K 10-Q · filed 2025-10-27 | |||
| 2024-06-30 | $124.68K 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $73.70K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $7.67K 10-K · filed 2025-03-13 | |||
| 2023-09-30 | $30.42K 10-Q · filed 2024-10-28 | |||
| 2023-06-30 | $18.75K 10-Q · filed 2024-07-30 | |||
| 2023-03-31 | -$2.10K 10-Q · filed 2024-05-03 | |||
| 2023-02-28 | -$7.46K 10-Q · filed 2024-05-17 | |||
| 2022-12-31 | $11.47K 10-K · filed 2024-03-29 | |||
| 2022-11-30 | $12.09K 10-Q · filed 2023-01-13 | |||
| 2022-09-30 | $7.44K 10-Q · filed 2023-10-31 | |||
| 2022-08-31 | $14.22K 10-K · filed 2022-11-01 | |||
| 2022-06-30 | $8.13K 10-Q · filed 2023-08-11 | |||
| 2022-05-31 | $22.42K 10-Q · filed 2022-07-13 | |||
| 2022-03-31 | $956.00 10-Q · filed 2023-05-15 | |||
| 2022-02-28 | $69.07K 10-Q · filed 2024-05-17 | |||
| 2021-11-30 | $94.10K 10-Q · filed 2023-01-13 | |||
| 2021-08-31 | -$18.59K 10-K · filed 2022-11-01 | |||
| 2021-05-31 | -$20.25K 10-Q · filed 2022-07-13 | |||
| 2021-02-28 | -$18.25K 10-Q · filed 2022-04-14 | |||
| 2020-05-31 | $22.87K 10-Q · filed 2021-07-14 | |||
| 2020-02-29 | $2.62K 10-Q · filed 2021-04-13 |